Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Sumiyuki Nishida"'
Autor:
Tomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara, Burcu Temizoz, Masanari Hamaguchi, Takayuki Shiroyama, Keiko Kimura, Kotaro Miyake, Haruhiko Hirata, Yumiko Mizuno, Mayu Yagita, Yusuke Manabe, Etsushi Kuroda, Yoshito Takeda, Hiroshi Kida, Ken J. Ishii, Atsushi Kumanogoh
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN) (K3)—a novel synthetic single-stranded DNA immune adjuvant for cancer immunotherapy—induces a potential Th1-type immune response against cancer cells. We conducted a ph
Externí odkaz:
https://doaj.org/article/8812c8d7ce2f4eff8b8439c505989aa3
Autor:
Yuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, Ryotaro Saita, Tomoharu Sato, Sayaka Nagao, Teruaki Murakami, Yuko Yoshimine, Saori Amiya, Takayoshi Morita, Yasutaka Okita, Takahiro Kawasaki, Jun Fujimoto, Yasutaka Ueda, Yuichi Maeda, Akane Watanabe, Hyota Takamatsu, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 32, Iss , Pp 100661- (2023)
Summary: Background: Autoimmune inflammatory rheumatic disease (AIRD) patients are at high risk of the coronavirus disease 2019 (COVID-19), but the medium-term effects of immunosuppressants on vaccine efficacy are unknown. We investigated the duratio
Externí odkaz:
https://doaj.org/article/4898804d69904fb1be692f12bb46c445
Autor:
Fumihiro Fujiki, Soyoko Morimoto, Akiko Katsuhara, Akane Okuda, Saeka Ogawa, Eriko Ueda, Maki Miyazaki, Ayako Isotani, Masahito Ikawa, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshihiro Oka, Jun Nakata, Naoki Hosen, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Memory T cells play an essential role in infectious and tumor immunity. Vitamin A metabolites such as retinoic acid are immune modulators, but the role of vitamin A metabolism in memory T-cell differentiation is unclear. In this study, we identified
Externí odkaz:
https://doaj.org/article/be408ef12699491a8d81c30d652284b0
Autor:
Eri Itotagawa, Yoshihiko Tomofuji, Yasuhiro Kato, Hachiro Konaka, Kohei Tsujimoto, JeongHoon Park, Daiki Nagira, Takehiro Hirayama, Tatsunori Jo, Toru Hirano, Takayoshi Morita, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Yukinori Okada, Hyota Takamatsu, Atsushi Kumanogoh
Publikováno v:
Rheumatology. 62:1988-1997
Objective B-cell activating factor (BAFF) is implicated in SLE pathogenesis. Blocking BAFF signalling has contributed to reducing glucocorticoid dosage and preventing organ damage. However, clinical characteristics of patients who may benefit from th
Autor:
Akiko Kajihara, Takayoshi Morita, Yasuhiro Kato, Hachiro Konaka, Teruaki Murakami, Yuta Yamaguchi, Shohei Koyama, Hyota Takamatsu, Masayuki Nishide, Yuichi Maeda, Akane Watanabe, Sumiyuki Nishida, Toru Hirano, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh
Publikováno v:
International Immunology. 35:27-41
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease, and many peripheral immune cell populations (ICPs) are thought to be altered according to the course of the disease. However, it is unclear which ICPs are associated with the c
Autor:
Akane Watanabe, Sumiyuki Nishida, Temizöz Burcu, Takayuki Shibahara, Takato Kusakabe, Etsushi Kuroda, Ken J. Ishii, Atsushi Kumanogoh
Publikováno v:
Vaccine. 40:4150-4159
Hydroxypropyl-β-cyclodextrin (HP-β-CyD), an oligosaccharide used as an excipient in pharmaceutical preparation, was recently reported to function as a vaccine adjuvant to co-administered antigens. In this study, we investigated the safety and immun
Autor:
Haruo Sugiyama, Satoshi Morita, Yoshihiro Oka, Sadamu Homma, Kei Ito, Hideaki Shimada, Masanori Kon, Michiaki Unno, Atsushi Kumanogoh, Hiroaki Nagano, Hidetoshi Eguchi, Fumihiro Fujiki, Soyoko Morimoto, Maho Sato, Mari Saito Oba, Hiroaki Yasuda, Satoshi Kokura, Yoshihide Kanno, Jun Ishii, Hiroaki Yanagimoto, Shigeo Koido, Shinichi Egawa, Takeshi Ishikawa, Sumiyuki Nishida
We investigated the efficacy of a Wilms' tumor gene 1 (WT1) vaccine combined with gemcitabine (GEMWT1) and compared it with gemcitabine (GEM) monotherapy for advanced pancreatic ductal adenocarcinoma (PDAC) in a randomized phase II study. We randomly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::478a1761e8fe3a19a7c2af5bcd283983
https://doi.org/10.1158/2326-6066.c.6549116.v1
https://doi.org/10.1158/2326-6066.c.6549116.v1
Autor:
Haruo Sugiyama, Satoshi Morita, Yoshihiro Oka, Sadamu Homma, Kei Ito, Hideaki Shimada, Masanori Kon, Michiaki Unno, Atsushi Kumanogoh, Hiroaki Nagano, Hidetoshi Eguchi, Fumihiro Fujiki, Soyoko Morimoto, Maho Sato, Mari Saito Oba, Hiroaki Yasuda, Satoshi Kokura, Yoshihide Kanno, Jun Ishii, Hiroaki Yanagimoto, Shigeo Koido, Shinichi Egawa, Takeshi Ishikawa, Sumiyuki Nishida
FACT-G subscale by treatment group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732ae84293eb4bc03cdf73b0b1c70167
https://doi.org/10.1158/2326-6066.22539539.v1
https://doi.org/10.1158/2326-6066.22539539.v1
Autor:
Fumihiro Fujiki, Soyoko Morimoto, Yuya Nishida, Satoe Tanii, Nao Aoyama, Miki Inatome, Kento Inoue, Akiko Katsuhara, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama
Publikováno v:
Cancer Immunology, Immunotherapy.
CD4+ T cells that recognize antigenic peptides presented on HLA class II are essential for inducing an optimal anti-tumor immune response, and adoptive transfer of tumor antigen-specific TCR-transduced CD4+ T cells with high responsiveness against tu
Autor:
Yuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, Ryotaro Saita, Tomoharu Sato, Sayaka Nagao, Teruaki Murakami, Yuko Yoshimine, Saori Amiya, Takayoshi Morita, Yasutaka Okita, Takahiro Kawasaki, Jun Fujimoto, Yasutaka Ueda, Yuichi Maeda, Akane Watanabe, Hyota Takamatsu, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh
Publikováno v:
The Lancet regional health. Western Pacific.
Autoimmune inflammatory rheumatic disease (AIRD) patients are at high risk of the coronavirus disease 2019 (COVID-19), but the medium-term effects of immunosuppressants on vaccine efficacy are unknown. We investigated the duration of humoral response